BIOCRYST PHARMACEUTICALS INC of DURHAM, NC filed a DEF 14A with the SEC on 2024-04-25. Industry: Biological Products, (No Diagnostic Substances).
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | DEF 14A |
| 2 | EX-101.SCH | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT |
| 3 | EX-101.DEF | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT |
| 4 | EX-101.LAB | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT |
| 5 | EX-101.PRE | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT |
| 6 | GRAPHIC | GRAPHIC |
| 7 | GRAPHIC | GRAPHIC |
| 8 | GRAPHIC | GRAPHIC |
| 9 | GRAPHIC | GRAPHIC |
| 10 | GRAPHIC | GRAPHIC |
| 11 | GRAPHIC | GRAPHIC |
| 23 | XML | EXTRACTED XBRL INSTANCE DOCUMENT |
Showing 12 of 60 filings.
| Filed | Form |
|---|---|
| 2026-04-23 | DEF 14A |
| 2026-04-23 | DEFA14A |
| 2025-04-24 | DEF 14A |
| 2025-04-24 | DEFA14A |
| 2024-04-25 | DEF 14A |
| 2024-04-25 | DEFA14A |
| 2023-04-27 | DEFA14A |
| 2023-04-27 | DEF 14A |
| 2022-05-26 | DEFA14A |
| 2022-04-25 | DEFA14A |
| 2022-04-25 | DEF 14A |
| 2021-04-13 | DEFA14A |